Company profile: Cambrian Bio
1.1 - Company Overview
Company description
- Provider of therapeutics to lengthen healthspan via a Distributed Development Company model, advancing programs targeting biological drivers of aging, including ATX-304 (a pan-AMPK activator for cardiometabolic diseases, Phase 1B), Tornado Therapeutics (developing mTOR inhibitors with novel selectivity profiles), and Telovance (a protein complex to enhance ex-vivo cell therapy expansion).
Products and services
- ATX-304: Clinical-stage pan-AMPK activator for cardiometabolic diseases, currently in Phase 1B clinical trials, engineered to broadly activate AMPK to treat cardiometabolic disease
- Telovance: Ex-vivo–stage protein complex used during the expansion stage of cell manufacturing to enhance cell therapies by supporting ex-vivo expansion
- Tornado Therapeutics: Novel-selectivity mTOR inhibitor programs engineered to extend human healthspan, focusing on safer and more effective treatments by developing inhibitors with differentiated selectivity profiles
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cambrian Bio
The Medicine Maker
HQ: United Kingdom
Website
- Description: Provider of a publication for persons involved in the development and manufacture of pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full The Medicine Maker company profile →
MDS Pharma Services
HQ: United States
Website
- Description: Provider of drug discovery and development solutions, including global clinical development (project management, clinical monitoring, and regulatory services), data management (integration, customized reports, CDISC-compliant exports), medical and scientific writing (ICH-compliant), independent quality assurance in North America and Europe, and central lab and centralized cardiac safety evaluation services for early drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MDS Pharma Services company profile →
Dottikon ES
HQ: Switzerland
Website
- Description: Provider of chemicals, intermediates, and active pharmaceutical ingredients for chemical, biotech, and pharmaceutical industries; cGMP API manufacturing; process development (R&D, routefinding, process design); small-, pilot-, and large-scale production with expertise in hazardous reactions and high-potency products; project and quality management; recycling and waste treatment including thermal recovery and waste water treatment and purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dottikon ES company profile →
Integrity Bio
HQ: United States
Website
- Description: Provider of contract development and manufacturing services focused on biologics formulation and GMP fill-finish. Offers formulation, process development, clinical and commercial production; cGMP analytical testing (chromatography, mass spectrometry, NMR); batch release and stability testing; separation science; analytical method development/validation; consultative services. Specializes in hard-to-formulate liquid and lyophilized products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integrity Bio company profile →
GlobalCare Clinical Trials
HQ: United States
Website
- Description: Provider of nursing and physician services as a pharmaceutical company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GlobalCare Clinical Trials company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cambrian Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cambrian Bio
2.2 - Growth funds investing in similar companies to Cambrian Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cambrian Bio
4.2 - Public trading comparable groups for Cambrian Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →